Searchable abstracts of presentations at key conferences in endocrinology

ea0026p478 | Thyroid cancer | ECE2011

Incidentally discovered thyroid carcinomas. An experience of a centre through 18 years

Lizarraga Aitzol , Paja Miguel , Sanchez Maider , Barrios Borja , Perez Josu , Arosa Vanessa

Incidental thyroid carcinoma includes thyroid carcinomas detected after surgery in patients whose thyroid has been correctly studied with no data of malignancy. Lately, the widely spread use of image techniques and thorough search of thyroid nodule complains, have lead to a growing number of thyroid carcinomas. But still there are some of these incidentally discovered after thyroidectomy.We report 98 cases of thyroid carcinomas incidentally found from a ...

ea0026p513 | Bone/calcium/Vitamin D | ECE2011

Influence of thyroid disease in diagnostic accuracy of Tc99m-sestamibi scintigraphy in patients with primary hyperparathyroidism (PHP)

Egana Nerea , Paja Miguel , Gutierrez Maria Teresa , Rodriguez Maria Luisa , Goni Fernando , Ugarte Estibaliz , Espiga Javier

Bilateral cervical exploration has been the gold standard in parathyroid surgery. Nowadays, the preoperative localization procedures have facilitated the minimally invasive surgery. This study aims to analyze the influence of thyroid disease in Tc99m-sestamibi scintigraphy (MIBI) results.A series of 154 patients with PHP who underwent parathyroidectomy was reviewed. Patients were divided into two groups: group 1 (G1, 58 patients) with thyroid diseases, a...

ea0026p555 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Polycystic ovary syndrome and their relationship with metabolic syndrome in female-to-male transsexuals

Becerra Antonio , Lopez Gilberto Perez , Menacho Miriam , Molina Jose Miguel Rodriguez , Lucio M Jesus , Asenjo Nuria

Objective: To determine the prevalence of polycystic ovary syndrome (PCOS) and hyperandrogenism and their relationships with metabolic syndrome (MS) parameters in female-to-male transsexuals (FMT).Design and methods: Seventy-seven FMT were assessed clinically and biochemically to hyperandrogenism, before the beginning of the treatment with testosterone. We also assessed cardiovascular risk factors and other parameters of MS.Results...

ea0025p289 | Steroids | SFEBES2011

Glucocorticoid receptor antagonism as a decision making tool in patients with adrenal incidentaloma and low-grade excess cortisol secretion: a pilot study

Debono Miguel , Houghton Sam , Eastell Richard , Ross Richard , Newell-Price John

Aims/hypothesis: Adrenal incidentaloma (AI) are very common, but optimal management of patients with AI and low-grade excess cortisol secretion is not established. Uncontrolled studies reporting outcomes of adrenalectomy suggest improvements in cardiovascular risk, but all are subject to selection bias, and it is unclear if benefits are due to removal of excess cortisol. We reasoned that short-term use of mifepristone, a rapidly-acting glucocorticoid receptor (GR) antagonist, ...

ea0022p101 | Bone/Calcium | ECE2010

Fine needle aspiration of parathyroid gland with PTH analysis in washouts: is it worthy?

Melo Miguel , Ribeiro Cristina , Paiva Sandra , Vieira Alexandra , Carrilho Francisco , Carvalheiro Manuela

Introduction: Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcaemia in the outpatient setting. Surgical remove of an adenoma or hyperplastic glands results in cure, but an accurate localization, preoperative whenever possible, is essential for success. Taking into consideration that parathyroid carcinoma is a rare event, FNA of parathyroid glands, complemented by PTH measurement in washouts (FNA/PTH), may be a useful tool in the diagnostic workout.<...

ea0022p240 | Clinical case reports and clinical practice | ECE2010

Synergic effect of Cabergoline in acromegaly treated with somatostatin analogues. Report of two cases

Paja Miguel , Perez-Yeboles Josu , Lizarraga Aitzol , Moreno Cristina , Isusquiza Ana , Elorza J Ramon

Current treatment for acromegaly includes dopamine agonists (DA), somatostatin receptor ligands (SRL) and GH receptor antagonists (GHRA). DA in monotherapy, is less than 10% effective achieving control of the disease, and its efficacy in addition to ongoing SRL is less studied, without obvious determining factors of response. We report 2 operated patients with incomplete response to SRL and to whom Cabergoline addition led to disease control.Case 1: A ma...

ea0022p712 | Obesity | ECE2010

Desacyl–ghrelin as a protective factor for obesity

Veiga Luisa , Silva-Nunes Jose , Melao Alice , Oliveira Ana , Duarte Leone , Brito Miguel

Background: Although acyl–ghrelin has been considered essential for ghrelin’s GH-releasing activity, several recent in vitro studies have shown that desacyl–ghrelin exhibits biological activities on metabolism and proliferation of adipocytes, myocytes, cardiomyocytes, and myelocytes. The full desacyl–ghrelin biological activity still remains a matter of debate.Aims: To assess desacyl–ghrelin circulating levels and its R51Q...

ea0022p718 | Obesity | ECE2010

Carbohydrate metabolism in obese women: association with the circulating levels of adiponectin and retinol binding protein-4

Silva-Nunes Jose , Melao Alice , Oliveira Ana , Duarte Leone , Brito Miguel , Veiga Luisa

Background: Adiponectin is an adipokine with anti-diabetic properties. Recently, retinol binding protein-4 (RBP4) was identified as an adipokine associated with insulin resistance (IR) and a potential marker for type 2 diabetes (T2D) development.Aims: To compare adiponectin and RBP4 circulating levels according to presence/absence of diabetes/prediabetes, in obese women. To study the degree of association of those adipokines with indexes of IR and insuli...

ea0022p838 | Thyroid | ECE2010

Simultaneous thyroid and gastric autoimmune disease: clinical aspects of 78 cases

Paja Miguel , Lizarraga Aitzol , Moreno Cristina , Ugarte Estibaliz , Perez-Yeboles Josu , Oleaga Amelia

Autoimmune polyendocrinopathy syndromes (APS) gather a wide range of diseases. The association of autoimmune thyroid disease (ATD) with other organ specific diseases is frequent. Atrophic body gastritis (ABP) is characterized by the loss of ClH and intrinsic factor (IF) production. Both ATD and ABP are known to be associated since 1960 but there are scarce publications describing its clinical features.We review patients with this association selected fro...

ea0021p345 | Steroids | SFEBES2009

Dexamethasone testing and visceral:subcutaneous fat ratios in patients with adrenal incidentalomas

Debono Miguel , Hughes Tim , Durrington Charlotte , Williams Scott , Newell-Price John

Background: The Endocrine Society clinical practice guidelines suggest use of the 1 mg overnight dexamethasone suppression test (ONDST) to screen for cortisol excess in patients with adrenal incidentalomas, followed by the 48-h, 2 mg/day, low-dose dexamethasone-suppression test (LDDST), to confirm a positive result. Visceral fat accumulates in cortisol-excess and accounts for increased cardiovascular risk. In this study, we investigate whether the LDDST offers additional infor...